Infectious Diseases 1611 - Infectious Disease Alert - Nov 01, 2012

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Co-Editor
Joseph F. John, JR, MD, MD, FACP, FIDSA, FSHEA
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina
Charleston

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Hal B. Jenson, MD, FAAP
Dean, Western Michigan University School of Medicine
Kalamazoo, Michigan

Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
Associate Professor of Internal Medicine,
Northeast Ohio Medical University
Rootstown, OH

Subjects:

  • Fungal meningitis and arthritis from epidural, paraspinal and intra-articular injections with contaminated corticosteroid. Early status.
  • Pediatric-Specific Antibiograms Improve Empiric Drug Selection
  • Fidaxomicin after Vancomycin for Patients with Multiple C. difficile Recurrences
  • Etiology of Acute Diarrhea in Children
  • Dengue in Vietnam Prompts Travel Warning
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Co-Editor
Joseph F. John, JR, MD, MD, FACP, FIDSA, FSHEA, Peer Reviewer Timothy Jenkins, MD, Associate Editors Hal B. Jenson, MD, FAAP, and Richard R. Watkins, MD, MS, FACP report no financial relationship relavent to this field of study. Copyright 2012 AHC Media. All rights reserved.